Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-04-050520
Filing Date
2004-03-26
Accepted
2004-03-26 15:12:17
Documents
11
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 ISTA FORM 10-K (31 DECEMBER 2003) d10k.htm 10-K 1303336
3 CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED BY-LAWS OF ISTA PHARMACEUTICAL dex34.htm EX-3.4 4866
4 AMNDMT #4 TO CONTRACT CLINICAL RESEARCH AGMT WITH CROMEDICA GLOBAL, 8/18/2003 dex1045.htm EX-10.45 231091
5 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1767
6 CERT OF CEO, AS REQUIRED BY SEC 302 OF SARBANES-OXLEY ACT OF 2002 dex311.htm EX-31.1 5954
7 CERT OF CFO, AS REQUIRED BY SEC 302 OF SARBANES-OXLEY ACT OF 2002 dex312.htm EX-31.2 6133
8 CERT OF CEO, AS REQUIRED BY SEC 906 OF SARBANES-OXLEY ACT OF 2002 dex321.htm EX-32.1 2879
9 CERT OF CFO, AS REQUIRED BY SEC 906 OF SARBANES-OXLEY ACT OF 2002 dex322.htm EX-32.2 2915
10 GRAPHIC g8753887538.jpg GRAPHIC 36551
11 GRAPHIC g87538g32w85.jpg GRAPHIC 67912
12 GRAPHIC g87538g63b64.jpg GRAPHIC 79866
  Complete submission text file 0001193125-04-050520.txt   1746350
Mailing Address 15279 ALTON PARKWAY 100 IRVINE CA 92618
Business Address 15279 ALTON PARKWAY 100 IRVINE CA 92618 9497886000
ISTA PHARMACEUTICALS INC (Filer) CIK: 0000930553 (see all company filings)

EIN.: 330511719 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31255 | Film No.: 04692749
SIC: 2835 In Vitro & In Vivo Diagnostic Substances